About Us Press Releases

2nd Hybrid Webinar on India-Malawi Pharmaceutical Cooperation and Regulatory Developments

Posted on: February 15, 2024 | Back | Print

High Commission of India


The High Commission of India in association with Pharmaceuticals Export Promotion Council of India (PHARMEXCIL) organized the Second Hybrid Webinar on “India-Malawi Pharmaceutical Cooperation and Regulatory Development” on 15 February 2024. 

High Commissioner His Excellency S. Gopalakrishnan, Mr. Ravi Uday Bhaskar, Director General, Pharmaceuticals Export Promotion Council of India, Mr. Charles Kombeni, Director (Procurement), Central Medical Store Trust and Mr. Godfrey Kadwere, Director, Ministry of Health, GoM made special remarks at the event. Mr. Mphatso Kawaye, Director General Pharmacy and Medicines Regulatory Authority of Malawi made a presentation on the pharma regulations in Malawi. 

The Indian pharmaceutical industry has emerged as a global leader  and India is the largest global supplier of generic drugs accounting for 20% of its global exports. India is also the leading vaccine manufacturer globally with a market share of 60%. The total annual turnover of Pharmaceuticals in the fiscal year 2021-22 was $42.34 Bn. Major segments of the Indian Pharmaceutical Industry include generic drugs, OTC medicines, bulk drugs, vaccines, contract research & manufacturing, biosimilars and biologics. During 2022-23, India’s pharmaceutical exports have crossed US$ 25 billion. India manufactures about 60,000 different generic brands across 60 therapeutic categories  and ranks 3rd  globally in manufacturing generic drugs. India is a global player in all pharma segments –patented, generic and over the counter drug market. Hence, India is called as the ‘Pharmacy of the world’. India’s pharmaceutical products are globally known including in Malawi for its quality as well as cost-effectiveness. 

The objective of the Webinar was to facilitate and promote more pharma trade between India and Malawi. The webinar was followed by B2B meetings. Over 100 companies from both India and Malawi participated at the second Hybrid  Buyer-Seller Meet on pharma sector. The first Buyer-Seller Meet was organised in February 2022.

15 February 2024